Acute hyperammonemic encephalopathy after 5-fluorouracil based chemotherapy

Ann Surg Treat Res. 2016 Mar;90(3):179-82. doi: 10.4174/astr.2016.90.3.179. Epub 2016 Feb 26.

Abstract

5-Fluorouracil (5-FU) based chemotherapy has been commonly used to treat metastatic or advanced colon cancer as an adjuvant chemotherapy. Although the side effects of 5-FU such as gastrointestinal problems and neutropenia and thrombocytopenia are common, not many cases of 5-FU related encephalopathy are reported. Hyperammonemic encephalopathy is a rare central nervous system toxicity following 5-FU chemotherapy manifesting as altered mental status with elevated ammonia levels with no radiologic abnormality. We report one case of 5-FU induced hyperammonemic encephalopathy occurring after Folfox4 (oxaliplatin, folinic acid and 5-fluorouracil) chemotherapy in a colon cancer patient who presented with confused mental status soon after the chemotherapy and review the 5-FU related encephalopathy.

Keywords: 5-Fluorouracil; Colorectal neoplasma; Hyperammonemia; Metabolic brain diseases.

Publication types

  • Case Reports